title: Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR.
abstract: Although microbial (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP) can activate primate Vgamma2Vdelta2 T cells, molecular mechanisms by which HMBPP interacts with Vgamma2Vdelta2 T cells remain poorly characterized. Here, we developed soluble, tetrameric Vgamma2Vdelta2 TCR of rhesus macaques to define HMBPP/APC interaction with Vgamma2Vdelta2 TCR. While exogenous HMBPP was associated with APC membrane in an appreciable affinity, the membrane-associated HMBPP readily bound to the Vgamma2Vdelta2 TCR tetramer. The Vgamma2Vdelta2 TCR tetramer was shown to bind stably to HMBPP presented on membrane by various APC cell lines from humans and nonhuman primates but not those from mouse, rat, or pig. The Vgamma2Vdelta2 TCR tetramer also bound to the membrane-associated HMBPP on primary monocytes, B cells and T cells. Consistently, endogenous phosphoantigen produced in Mycobacterium-infected dendritic cells was transported and presented on membrane, and bound stably to the Vgamma2Vdelta2 TCR tetramer. The capability of APC to present HMBPP for recognition by Vgamma2Vdelta2 TCR was diminished after protease treatment of APC. Thus, our studies elucidated an affinity HMBPP-APC association conferring stable binding to the Vgamma2Vdelta2 TCR tetramer and the protease-sensitive nature of phosphoantigen presentation. The findings defined APC presentation of phosphoantigen HMBPP to Vgamma2Vdelta2 TCR.
authors.affiliation: Department of Microbiology and Immunology, Center for Primate Biomedical Research, University of Illinois College of Medicine Chicago, Chicago, Illinois 60612, USA.
authors.forename: Huiyong
authors.initials: H
authors.lastname: Wei
authors.forename: Dan
authors.initials: D
authors.lastname: Huang
authors.forename: Xiaomin
authors.initials: X
authors.lastname: Lai
authors.forename: Meiling
authors.initials: M
authors.lastname: Chen
authors.forename: Weihua
authors.initials: W
authors.lastname: Zhong
authors.forename: Richard
authors.initials: R
authors.lastname: Wang
authors.forename: Zheng W
authors.initials: ZW
authors.lastname: Chen
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D017951:Antigen Presentation / Q000235:genetics / Q000276:immunology*; D000938:Antigen-Presenting Cells / Q000276:immunology* / Q000378:metabolism*; D000942:Antigens, Bacterial / Q000096:biosynthesis / Q000276:immunology / Q000378:metabolism*; D002460:Cell Line; D045744:Cell Line, Tumor; D003713:Dendritic Cells / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D019281:Dimerization; D006801:Humans; D008253:Macaca mulatta; D051379:Mice; D008969:Molecular Sequence Data; D010755:Organophosphates / Q000737:chemistry / Q000276:immunology / Q000378:metabolism*; D010750:Phosphoproteins / Q000276:immunology / Q000378:metabolism*; D011485:Protein Binding / Q000276:immunology; D051381:Rats; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D013552:Swine; D020298:U937 Cells
chemical_list: C467061:4-hydroxy-3-methyl-2-butenyl diphosphate; D000942:Antigens, Bacterial; D010755:Organophosphates; D010750:Phosphoproteins; D016692:Receptors, Antigen, T-Cell, gamma-delta; D011993:Recombinant Fusion Proteins
references.citation: Immunol Rev. 2007 Feb;215:123-35
references.pmid: 17291284
references.citation: Cytometry. 1999 Dec 15;38(6):280-5
references.pmid: 10589043
references.citation: Cancer Res. 2007 Aug 1;67(15):7450-7
references.pmid: 17671215
references.citation: Infect Immun. 1998 Mar;66(3):1190-9
references.pmid: 9488413
references.citation: J Immunol. 1995 Feb 1;154(3):998-1006
references.pmid: 7529807
references.citation: Cell Microbiol. 2003 Jul;5(7):445-53
references.pmid: 12814435
references.citation: J Immunol. 2000 Dec 15;165(12):7133-9
references.pmid: 11120844
references.citation: J Virol. 2001 May;75(10):4713-20
references.pmid: 11312343
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4560-5
references.pmid: 15070757
references.citation: J Biol Chem. 1999 Nov 5;274(45):32079-84
references.pmid: 10542241
references.citation: Tuber Lung Dis. 1999;79(5):279-85
references.pmid: 10707256
references.citation: Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11408-12
references.pmid: 7972074
references.citation: Microbes Infect. 2005 Mar;7(3):518-28
references.pmid: 15777667
references.citation: Eur J Immunol. 2004 Aug;34(8):2248-56
references.pmid: 15259022
references.citation: J Exp Med. 1990 Apr 1;171(4):1171-88
references.pmid: 2182762
references.citation: J Immunol. 1991 Jan 1;146(1):35-9
references.pmid: 1824593
references.citation: Biotechnology (N Y). 1993 Oct;11(10):1138-43
references.pmid: 7764094
references.citation: J Biol Chem. 1996 Aug 16;271(33):20156-62
references.pmid: 8702739
references.citation: Microbes Infect. 2005 Mar;7(3):503-9
references.pmid: 15823511
references.citation: J Immunol. 2001 Jul 1;167(1):36-41
references.pmid: 11418629
references.citation: J Immunol. 2007 Dec 15;179(12):8287-96
references.pmid: 18056373
references.citation: J Immunol. 2001 Apr 1;166(7):4525-33
references.pmid: 11254709
references.citation: J Immunol. 2005 Oct 15;175(8):5481-8
references.pmid: 16210656
references.citation: J Biol Chem. 1993 Jul 25;268(21):15455-60
references.pmid: 8340374
references.citation: J Immunol. 2003 Apr 1;170(7):3696-706
references.pmid: 12646635
references.citation: Annu Rev Immunol. 2005;23:515-48
references.pmid: 15771580
references.citation: Immunol Rev. 2007 Feb;215:46-58
references.pmid: 17291278
references.citation: J Exp Med. 2003 Jan 20;197(2):163-8
references.pmid: 12538656
references.citation: Hum Immunol. 1997 Dec;58(2):70-82
references.pmid: 9475336
references.citation: Protein Sci. 1999 Apr;8(4):921-9
references.pmid: 10211839
references.citation: Science. 1996 Oct 4;274(5284):94-6
references.pmid: 8810254
references.citation: Scand J Immunol. 1999 Dec;50(6):642-50
references.pmid: 10607313
references.citation: Infect Immun. 2008 Jan;76(1):426-36
references.pmid: 17923514
references.citation: Trends Immunol. 2003 Apr;24(4):213-9
references.pmid: 12697454
references.citation: FEBS Lett. 2001 Dec 7;509(2):317-22
references.pmid: 11741609
references.citation: Nat Biotechnol. 2004 Nov;22(11):1429-34
references.pmid: 15502816
references.citation: Infect Immun. 1996 Mar;64(3):913-8
references.pmid: 8641800
references.citation: J Infect Dis. 1999 Sep;180(3):858-61
references.pmid: 10438380
references.citation: J Urol. 2005 May;173(5):1552-6
references.pmid: 15821484
references.citation: FEBS Lett. 2003 Jun 5;544(1-3):4-10
references.pmid: 12782281
references.citation: Immunol Rev. 2007 Feb;215:77-88
references.pmid: 17291280
references.citation: Blood. 2008 Apr 15;111(8):4220-32
references.pmid: 18039956
references.citation: Curr Biol. 1993 Oct 1;3(10):658-67
references.pmid: 15335856
references.citation: J Immunol. 2004 Apr 1;172(7):4167-75
references.pmid: 15034029
references.citation: Nature. 2001 Jun 14;411(6839):820-4
references.pmid: 11459064
references.citation: Science. 1990 Nov 30;250(4985):1269-73
references.pmid: 1978758
references.citation: Science. 2002 Mar 22;295(5563):2255-8
references.pmid: 11910108